Table 1.
Patient characteristics (* pro-BNP was not measured routinely; abbreviations see text)
| Contrast-enhanced TEE | Control group | p value | |
|---|---|---|---|
| n |
90 |
90 |
|
| Age |
65.9±12 |
64.5±13 |
0.474 |
| female, % |
32.2 |
24.4 |
0.247 |
| BMI, kg/m2 |
27.9±5.0 |
26.2±4.1 |
0.111 |
| history of TIA/Stroke, % |
4.8 |
2.7 |
0.522 |
| COPD ≥ °II, % |
4.8 |
8.2 |
0.433 |
| diabetes mellitus, % |
21.3 |
13.7 |
0.244 |
| hypertension, % |
58.7 |
60.3 |
0.855 |
| CAD, % |
27.7 |
28 |
0.968 |
| previous.MI, % |
4.8 |
6.8 |
0.606 |
| hyperlipoproteinemia, % |
20.6 |
20.3 |
0.958 |
| heart rate 1/min |
91.7±26 |
92.8±24 |
0.803 |
| antiocoagulation ≥1 day (prior to TEE, %) |
51 |
48 |
0.764 |
| antiocoagulation ≥3w (prior to TEE, %) |
13 |
11 |
0.544 |
| hemoglobinn (g/dl) |
14.2±1.7 |
14.3±1.7 |
0.834 |
| pro-BNP (pg/ml) * |
1817±1700* |
* |
* |
| creatinine (mg/dl) |
1.1±0.49 |
1.1±0.28 |
0.728 |
| potassium (mmol/l) |
4.2±0.43 |
4.2±0.43 |
0.928 |
| C-reactive protein (mg/dl) | 1.1±2.1 | 1.5±2.9 | 0.377 |